-
EP3384899
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3384899
| EP3384899 - PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 19.05.2022 Database last updated on 02.09.2024 | |
| Former | Request for examination was made Status updated on 07.09.2018 | Most recent event Tooltip | 28.03.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states PIERRE FABRE MEDICAMENT Les Cauquillous 81500 Lavaur / FR | [2023/52] |
| Former [2018/41] | For all designated states Pierre Fabre Dermatologie 45, Place Abel Gance 92100 Boulogne Billancourt / FR | Inventor(s) | 01 /
CHAUMONT, Christine c/o Pierre Fabre Dermatologie 45 place Abel Gance 92100 BOULOGNE-BILLANCOURT / FR | 02 /
CORDOLIANI, Jean-François c/o Pierre Fabre Dermatologie 45 place Abel Gance 92100 BOULOGNE-BILLANCOURT / FR | 03 /
LEVERD, Élie c/o Pierre Fabre Dermatologie 45 place Abel Gance 92100 BOULOGNE-BILLANCOURT / FR | 04 /
MUGUET, Valérie c/o Pierre Fabre Dermatologie 45 place Abel Gance 92100 BOULOGNE-BILLANCOURT / FR | [2018/41] | Representative(s) | Novagraaf Technologies Bâtiment O2 2, rue Sarah Bernhardt CS90017 92665 Asnières-sur-Seine Cedex / FR | [2018/41] | Application number, filing date | 18174428.5 | 12.04.2010 | [2018/41] | Priority number, date | EP20090290298 | 21.04.2009 Original published format: EP 09290298 | [2018/41] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3384899 | Date: | 10.10.2018 | Language: | EN | [2018/41] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.07.2018 | Classification | IPC: | A61K9/00, A61K31/13 | [2018/41] | CPC: |
A61K9/08 (EP,KR,US);
A61K47/38 (KR,US);
A61K31/00 (KR,US);
A61K31/138 (EP,KR,US);
A61P35/00 (EP);
A61P43/00 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2018/41] | Extension states | AL | 25.05.2018 | BA | 25.05.2018 | ME | 25.05.2018 | RS | 25.05.2018 | Title | German: | PÄDIATRISCHE LÖSUNGEN MIT EINEM BETA-BLOCKER | [2018/41] | English: | PAEDIATRIC SOLUTIONS COMPRISING A BETA-BLOCKER | [2018/41] | French: | SOLUTIONS PÉDIATRIQUES COMPORTANT UN BÊTABLOQUANT | [2018/41] | Examination procedure | 25.05.2018 | Examination requested [2018/41] | 25.05.2018 | Date on which the examining division has become responsible | 04.04.2019 | Amendment by applicant (claims and/or description) | 18.05.2022 | Despatch of a communication from the examining division (Time limit: M04) | 26.08.2022 | Reply to a communication from the examining division | Parent application(s) Tooltip | EP10717263.7 / EP2421504 | EP12155472.9 / EP2497461 | Fees paid | Renewal fee | 25.05.2018 | Renewal fee patent year 03 | 25.05.2018 | Renewal fee patent year 04 | 25.05.2018 | Renewal fee patent year 05 | 25.05.2018 | Renewal fee patent year 06 | 25.05.2018 | Renewal fee patent year 07 | 25.05.2018 | Renewal fee patent year 08 | 25.05.2018 | Renewal fee patent year 09 | 26.03.2019 | Renewal fee patent year 10 | 30.03.2020 | Renewal fee patent year 11 | 24.03.2021 | Renewal fee patent year 12 | 25.03.2022 | Renewal fee patent year 13 | 22.03.2023 | Renewal fee patent year 14 | 27.03.2024 | Renewal fee patent year 15 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XI]US4600708 (REUTER GERALD L [US], et al) [X] 1-6,10-12,15,17,18 * column 1, line 25 - line 33 * * column 1, line 47 - line 62 * * column 2, line 20 - line 45 * * column 3, line 6 - column 4, line 31 * * examples 2-10 * [I] 7-9,13,14,16,19-21; | [X]GB2264866 (SYNEPOS AG [LI]) [X] 1-3,6,8-11,15,17 * page 1, line 1 - line 13 * * page 3, line 16 - line 27 * * page 4, line 1 - line 11 * * page 5, line 1 - line 30 * * examples 1-11 *; | [XI]DE102006020604 (BAYER HEALTHCARE AG [DE]) [X] 1-6,8-11,13,15,17 * paragraphs [0007] - [0018] * * paragraph [0024] * * examples 1-5,10 * * claims 1-5 * [I] 7,12,14,16,18-21; | [A] - C.LEAUTE; E. DUMAS DE LA ROQUE; T: HUBICHE; F: BORALEVI; JB THAMBO; A. TAIEB, "propranolol for severe hemangiomas of infancy", N ENG JOURNAL OF MEDECINE, (20080612), vol. 358, no. 24, pages 2649 - 2651, XP002546760 [A] 16 * the whole document * DOI: http://dx.doi.org/10.1056/NEJMc0708819 | [I] - TAKAHASHI N., MUROTA H., SUTOH I., "Antimicrobial activity of topical beta-adrenergic blocking agents", OPHTALMIC RES., (1983), vol. 15, no. 6, pages 277 - 279, XP008112326 [I] 20,21 * the whole document * |